The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results

被引：0

作者：

D'Haens, G. ^{[1
]}

Tran, J. ^{[2
,3
]}

Danese, S. ^{[4
]}

Rubin, D. T. ^{[5
]}

Aoyama, N. ^{[6
,7
]}

Lugering, A. ^{[8
]}

Klaff, J.

Xuan, S. ^{[3
]}

Ilo, D. ^{[3
]}

Gonzalez, Y. Sanchez ^{[3
]}

Panes, J. ^{[9
]}

机构：

[1] Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[2] Univ Washington, Comparat Hlth Outcomes Policy & Econ Inst, Seattle, WA USA

[3] AbbVie Inc, Chicago, IL USA

[4] Univ Vita Salute San Raffaele, Milan, Italy

[5] Univ Chicago Med, Ctr Inflammatory Bowel Dis, Chicago, IL USA

[6] Aoyama Med Clin, Dept Gastroenterol Gastrointestinal Endoscopy, Kobe, Japan

[7] IBD Ctr, Kobe, Japan

[8] MVZ Portal10, Munster, Germany

[9] Hosp Clin Barcelona, IDIPABS, CIBERehd, Barcelona, Spain

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OP20

引用

页码：I27 / I29

页数：4

共 50 条

[1] Effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
Pudipeddi, A.
D'Haens, G.
Tran, J.
Danese, S.
Rubin, D. T.
Aoyama, N.
Luegering, A.
Klaff, J.
Xuan, S.
Ilo, D.
Gonzalez, Y. Sanchez
Panes, J.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 137 - 138
[2] THE EFFECTS OF UPADACITINIB ON ULCERATIVE COLITIS SYMPTOM RESOLUTION AND FATIGUE NORMALIZATION IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U-ACHIEVE AND U-ACCOMPLISH RESULTS
D'Haens, Geert
Tran, Jacinda N.
Danese, Silvio
Rubin, David T.
Aoyama, Nobuo
Lugering, Andreas
Klaff, Justin
Xuan, Si
Ilo, Dapo
Gonzalez, Yuri Sanchez
Panes, Julian
GASTROENTEROLOGY, 2023, 164 (06) : S1102 - S1103
[3] Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE study
D'Haens, G.
Hebuterne, X.
Higgins, P. D. R.
Loftus, E. V., Jr.
Zhou, W.
Lacerda, A. P.
Xie, W.
Liu, J.
Danese, S.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S580 - S581
[4] UPADACITINIB WAS NOT ASSOCIATED WITH ANAEMIA IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE U-ACHIEVE STUDY
D'Haens, Geert R.
Hebuterne, Xavier
Higgins, Peter D.
Loftus, Edward V.
Zhou, Wen
Lacerda, Ana P.
Xie, Wangang
Liu, Jianzhong
Danese, Silvio
GASTROENTEROLOGY, 2020, 158 (06) : S1205 - S1206
[5] Efficacy and Safety of Upadacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Phase 3 U-ACCOMPLISH Study
Vermeire, Severine
Danese, Silvio
Zhou, Wen
Pangan, Aileen
Greenbloom, Susan
D'Haens, Geert
Panes, Julian
Juillerat, Pascal
Lindsay, James
Loftus, Edward V.
Sandborn, William
Reinisch, Walter
Sanchez-Gonzalez, Yuri
Huang, Bidan
Xian, Wangang
Liu, Jianzhong
Weinreich, Michael
Panaccione, Remo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S357 - S357
[6] Efficacy and safety of upadacitinib as induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from phase 3 U-ACCOMPLISH study
Vermeire, S.
Danese, S.
Zhou, W.
Pangan, A.
Greenbloom, S.
D'Haens, G.
Panes, J.
Juillerat, P.
Lindsay, J. O.
Loftus, E. V., Jr.
Sandborn, W. J.
Reinisch, W.
Gonzalez, Y. Sanchez
Huang, B.
Xie, W.
Liu, J.
Weinreich, M. A.
Panaccione, R.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S021 - S022
[7] The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
Danese, S.
Tran, J.
D'Haens, G.
Rubin, D. T.
Aoyama, N.
Zhou, W.
James, B.
Yao, X.
Gonzalez, Y. Sanchez
Panaccione, R.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I008 - I009
[8] Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 U-ACHIEVE Study
Danese, Silvio
Vermeire, Severine
Zhou, Wen
Pangan, Aileen
Siffledeen, Jesse
Hebuterne, Xavier
Nakase, Hiroshi
Chen, Minhu
Higgins, Peter
Sanchez-Gonzalez, Yuri
Huang, Bidan
Xian, Wangang
Liu, Jianzhong
Weinreich, Michael
Panaccione, Remo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S312 - S313
[9] Efficacy and safety of upadacitinib induction therapy in patients with Moderately to Severely Active Ulcerative Colitis: Results from the phase 3 U-ACHIEVE study
Danese, S.
Vermeire, S.
Zhou, W.
Pangan, A.
Siffledeen, J.
Hebuterne, X.
Nakase, H.
Higgins, P.
Chen, M. H.
Sanchez-Gonzalez, Y.
Huang, B.
Xie, W.
Liu, J.
Weinreich, M.
Pannaccione, R.
JOURNAL OF CROHNS & COLITIS, 2021, 15 : S022 - S024
[10] Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Study
Vermeire, Severine
Danese, Silvio
Zhou, Wen
Yao, Xuan
Ilo, Dapo
Liu, John
Hebuterne, Xavier
Lindsay, James
Sanchez-Gonzalez, Yuri
Higgins, Peter D.
Colombel, Jean-Frederic
Panaccione, Remo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S521 - S522

← 1 2 3 4 5 →